Sign up to save your podcasts
Or
Share SGLT2 inhibitors and how we use them
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
SGLT2 inhibitors and how we use them
In this podcast, Dr Rick Cutfield discusses the management of type two diabetes mellitus following the introduction of new funded medication in NZ.
He covers the importance of lifestyle, medication, and support at every step, and also the pharmacological management including the new stepwise approach to management.
Indications and precautions of the new classes of subsidised medications: Sodium glucose co-transporter 2 (SGLT-2) inhibitors, and briefly Glucagon like peptide-1 receptor (GLP-1) agonists are also covered.
View all episodes
By Goodfellow UnitIn this podcast, Dr Rick Cutfield discusses the management of type two diabetes mellitus following the introduction of new funded medication in NZ.
He covers the importance of lifestyle, medication, and support at every step, and also the pharmacological management including the new stepwise approach to management.
Indications and precautions of the new classes of subsidised medications: Sodium glucose co-transporter 2 (SGLT-2) inhibitors, and briefly Glucagon like peptide-1 receptor (GLP-1) agonists are also covered.
More shows like Goodfellow Unit
View all
Conversations
862 Listeners
Nine To Noon
21 Listeners
Medicine and Science from The BMJ
40 Listeners
Mamamia Out Loud
590 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
The Good GP
20 Listeners
BMJ Best Practice Podcast
24 Listeners
Primary Care Knowledge Boost
47 Listeners
The New Zealand General Practice Podcast
1 Listeners
The Detail
53 Listeners
The Imperfects
442 Listeners
GPnotebook Podcast
17 Listeners
NB Hot Topics Podcast
6 Listeners
ZOE Science & Nutrition
2,029 Listeners
Red Whale Primary Care Pod
5 Listeners